Stocks
HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS
Reference is made to the stock exchange announcements from Hofseth BioCare ASA ("HBC" or the "Company") published on 26 June 2026 and 29 June 2026 regarding a private placement (the "Private Placement") of new ordinary shares ("Offer Shares") at a fixed price per share of NOK 1.30 (the "Offer Price"), which raised gross proceeds of approximately NOK 144.5 million. The following shareholders of the Company have, on 28 June 2026, been allocated new shares in the Private Placement which implies tha
About this update from Hofseth Biocare Asa
Reference is made to the stock exchange announcements from Hofseth BioCare ASA ("HBC" or the "Company") published on 26 June 2026 and 29 June 2026 regarding a private placement (the "Private Placement") of new ordinary shares ("Offer Shares") at a fixed price per share of NOK 1.30 (the "Offer Price"), which raised gross proceeds of approximately NOK 144.5 million. The following shareholders of the Company have, on 28 June 2026, been allocated new shares in the Private Placement which implies that their holdings have surpassed a notifiable threshold: The following shareholders have had their holdings diluted as a consequence of the Private Placement and thereby passed a notifiable threshold:
View stock analysis, news, and events for Hofseth Biocare Asa